Amgen, Inc. : Amgen Sets Pricing on Euro and Sterling Bond
09/10/2012| 04:20am US/Eastern
By Sarka Halas
U.S.-based biotechnology company Amgen Inc. (AMGN) has set pricing on its two-part, euro and sterling denominated bond, one of the banks running the deal said Monday.
Pricing on the 17-year euro bond was set in the range of 80 to 85 basis points over midswaps, while pricing on the seven-year sterling part was set in the area of 190 basis points over gilts.
Barclays PLC, Citigroup Inc., and Deutsche Bank AG are the lead managers on the deal, which is expected to price later Monday.
The issuer is rated Baa1 by Moody's Investor Services, A+ by Standard and Poor's Corp., and BBB by Fitch Ratings.
Write to Sarka Halas at email@example.com